Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Halfon

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinics and Research in Hepatology and Gastroenterology|June 19, 2021
High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysisMatthieu Halfon, Florent Artru, Montserrat Fraga, et al.
JIMD Reports|November 12, 2021
A stone in the boneMatthieu Halfon, Pierre Cochat, Sebastien Kissling, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2020
CD62L on blood basophils: a first pre-treatment predictor of remission in severe lupus nephritisMatthieu Halfon, Delphine Bachelet, Guillaume Hanouna, et al.
Kidney International|May 31, 2020
Collapsing glomerulopathy in a COVID-19 patientSébastien Kissling, Samuel Rotman, Christel Gerber, et al.
Genes|May 27, 2023
ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification PropensityMatthieu Halfon, Li Zhang, Driss Ehirchiou, et al.
Blood Pressure|September 30, 2017
Use of oscillometric devices in atrial fibrillation: a comparison of three devices and invasive blood pressure measurementMatthieu Halfon, Gregoire Wuerzner, Pedro Marques-Vidal, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 13, 2018
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantationYannick D Muller, Nseir Ghaleb, Samuel Rotman, et al.
Kidney International Reports|January 15, 2025
Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative GlomerulonephritisMatthieu Halfon, Patrick Taffé, Christian Bucher, et al.
Kidney360|May 14, 2026
Impact of Disease Recurrence and Outcomes following Kidney Transplantation for Glomerulonephritis: A Prospective Nationwide Cohort StudyMatthieu Halfon, Patrick Taffé, Christian Bucher, et al.
Transplantation Direct|April 21, 2025
Association of Kidney Graft Long-term Outcome With Recipient Cystathionine Gamma-lyase Polymorphisms and Hydrogen Sulfide Levels: A Cohort StudyMatthieu Halfon, Raffaella Emsley, Thomas Agius, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinics and Research in Hepatology and Gastroenterology|June 19, 2021
High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysisMatthieu Halfon, Florent Artru, Montserrat Fraga, et al.
JIMD Reports|November 12, 2021
A stone in the boneMatthieu Halfon, Pierre Cochat, Sebastien Kissling, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2020
CD62L on blood basophils: a first pre-treatment predictor of remission in severe lupus nephritisMatthieu Halfon, Delphine Bachelet, Guillaume Hanouna, et al.
Kidney International|May 31, 2020
Collapsing glomerulopathy in a COVID-19 patientSébastien Kissling, Samuel Rotman, Christel Gerber, et al.
Genes|May 27, 2023
ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification PropensityMatthieu Halfon, Li Zhang, Driss Ehirchiou, et al.
Blood Pressure|September 30, 2017
Use of oscillometric devices in atrial fibrillation: a comparison of three devices and invasive blood pressure measurementMatthieu Halfon, Gregoire Wuerzner, Pedro Marques-Vidal, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 13, 2018
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantationYannick D Muller, Nseir Ghaleb, Samuel Rotman, et al.
Kidney International Reports|January 15, 2025
Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative GlomerulonephritisMatthieu Halfon, Patrick Taffé, Christian Bucher, et al.
Kidney360|May 14, 2026
Impact of Disease Recurrence and Outcomes following Kidney Transplantation for Glomerulonephritis: A Prospective Nationwide Cohort StudyMatthieu Halfon, Patrick Taffé, Christian Bucher, et al.
Transplantation Direct|April 21, 2025
Association of Kidney Graft Long-term Outcome With Recipient Cystathionine Gamma-lyase Polymorphisms and Hydrogen Sulfide Levels: A Cohort StudyMatthieu Halfon, Raffaella Emsley, Thomas Agius, et al.
Pageof 4